<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DEMECLOCYCLINE HYDROCHLORIDEÂ - demeclocycline hydrochlorideÂ tabletÂ </strong><br>Amneal Pharmaceuticals<br></p></div>
<h1>
<span class="Bold">DEMECLOCYCLINE HYDROCHLORIDE Tablets, USP</span><span class="Bold"><br></span><span class="Bold">
(Film Coated) </span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<h1><span class="Bold"></span></h1>
<p class="First"><span class="Bold">Full Prescribing Information </span></p>
<p>To reduce the development of drug-resistant bacteria and maintain the effectiveness of demeclocycline hydrochloride tablets and other antibacterial drugs, demeclocycline hydrochloride tablets should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION
</span></h1>
<p class="First">Demeclocycline hydrochloride is an antibiotic isolated from a mutant <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> of <span class="Italics">Streptomyces aureofaciens</span>. Chemically it is 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12, 12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride.<br><br>Its structural formula is:</p>
<div class="Figure"><img alt="8849f977-figure-01" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4ff23e3b-e111-47fd-9776-1d89d6da049b&amp;name=8849f977-figure-01.jpg"></div>
<p><br>Demeclocycline hydrochloride film coated tablets for oral administration contain 150 mg or 300 mg of demeclocycline hydrochloride and the following inactive ingredients: alginic acid, corn starch, ethylcellulose, FD&amp;C Red 40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium lauryl sulfate, talc and titanium dioxide. In addition, the 150 mg tablet contains D&amp;C Red 27 aluminum lake.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY
</span></h1>
<p class="First"><span class="Bold">Pharmacokinetics </span><span class="Bold"><br></span>The absorption of demeclocycline is slower than that of tetracycline. The time to reach the peak concentration is about 4 hours. After a 150 mg oral dose of demeclocycline tablet, the mean concentrations at 1 hour and 3 hours are 0.46 and 1.22 mcg/mL (n = 6), respectively.<br>The serum half-life ranges between 10 and 16 hours.</p>
<p>When demeclocycline hydrochloride is given concomitantly with some dairy products, or antacids containing aluminum, calcium, or magnesium, the extent of absorption is reduced by more than 50%.<br></p>
<p>Demeclocycline hydrochloride penetrates well into various body fluids and tissues. The percent of demeclocycline hydrochloride bound to plasma protein is about 40% using a dialysis equilibrium method and 90% using an ultra-filtration method. Demeclocycline hydrochloride, like other tetracyclines, is concentrated in the liver and excreted into the bile where it is found in much higher concentrations than in the blood. The rate of demeclocycline hydrochloride renal clearance (35 mL/min/1.73 m<span class="Sup">2</span>) is less than half that of tetracycline. Following a single 150 mg dose of demeclocycline hydrochloride in normal volunteers, 44% (n = 8) was excreted in urine and 13% and 46%, respectively, were excreted in feces in two patients within 96 hours as active drug.</p>
<p><span class="Bold">Microbiology </span><span class="Bold"><br></span>The tetracyclines are primarily bacteriostatic and are thought to exert their antimicrobial effect by the inhibition of protein synthesis. The tetracyclines, including demeclocycline, have a similar antimicrobial spectrum of activity against a wide range of gram-negative and gram-positive organisms. Cross-resistance of these organisms to tetracyclines is common.</p>
<p>Demeclocycline has been shown to be active against most <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following microorganisms, both <span class="Italics">in vitro </span>and in clinical <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> as described in the <span class="Bold">INDICATIONS AND USAGE </span>section.</p>
<p><br></p>
<table frame="void" width="590">
<thead><tr class="First Last"><td align="left" colspan="2" valign="top"> AEROBIC GRAM-POSITIVE MICROORGANISMS:</td></tr></thead>
<tbody>
<tr class="First">
<td align="left" valign="top"><span class="Italics">Bacillus anthracis</span></td>
<td align="left" valign="top"><span class="Italics">Listeria monocytogenes </span></td>
</tr>
<tr class="Last">
<td align="left" valign="top"><span class="Italics">Staphylococcus aureus </span></td>
<td align="left" valign="top"><span class="Italics">Streptococcus pneumoniae </span></td>
</tr>
</tbody>
</table>
<p><span class="Italics"><br></span></p>
<table frame="void" width="590">
<thead><tr class="First Last"><td align="left" colspan="2" valign="top"> AEROBIC GRAM-NEGATIVE MICROORGANISMS:</td></tr></thead>
<tbody>
<tr class="First">
<td align="left" valign="top"><span class="Italics">Bartonella bacilliformis</span></td>
<td align="left" valign="top">
<span class="Italics">Brucella </span>species </td>
</tr>
<tr>
<td align="left" valign="top"><span class="Italics">Calymmatobacterium granulomatis </span></td>
<td align="left" valign="top"><span class="Italics">Campylobacter fetus </span></td>
</tr>
<tr>
<td align="left" valign="top"><span class="Italics">Francisella tularensis </span></td>
<td align="left" valign="top"><span class="Italics">Haemophilus ducreyi </span></td>
</tr>
<tr>
<td align="left" valign="top"><span class="Italics">Haemophilus influenzae </span></td>
<td align="left" valign="top"><span class="Italics">Neisseria gonorrhoeae </span></td>
</tr>
<tr class="Last">
<td align="left" valign="top"><span class="Italics">Vibrio cholerae </span></td>
<td valign="top">Yersinia pestis</td>
</tr>
</tbody>
</table>
<p>Because many <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following groups of gram-negative microorganisms have been shown to be resistant to tetracyclines, culture and susceptibility testing are especially recommended:</p>
<table frame="void" width="590">
<thead><tr class="First Last"><td align="left" colspan="2" valign="top"></td></tr></thead>
<tbody>
<tr class="First">
<td align="left" valign="top">
<span class="Italics">Acinetobacter </span>species </td>
<td align="left" valign="top"><span class="Italics">Enterobacter aerogenes </span></td>
</tr>
<tr>
<td align="left" valign="top"><span class="Italics">Escherichia coli </span></td>
<td align="left" valign="top">
<span class="Italics">Klebsiella </span>species </td>
</tr>
<tr class="Last">
<td valign="top">Shigella species</td>
<td align="left" valign="top"></td>
</tr>
</tbody>
</table>
<table frame="void" width="590">
<thead><tr class="First Last"><td align="left" colspan="2" valign="middle"> OTHER MICROORGANISMS: </td></tr></thead>
<tbody>
<tr class="First">
<td align="left" valign="top"><span class="Italics">Actinomyces israelii</span></td>
<td align="left" valign="top"><span class="Italics">Borrelia recurrentis </span></td>
</tr>
<tr>
<td align="left" valign="top"><span class="Italics">Chlamydia psittaci </span></td>
<td align="left" valign="top"><span class="Italics">Chlamydia trachomatis</span></td>
</tr>
<tr>
<td align="left" valign="top">
<span class="Italics">Clostridium </span>species</td>
<td align="left" valign="top">
<span class="Italics">Entamoeba </span>species </td>
</tr>
<tr>
<td align="left" valign="top"><span class="Italics">Fusobacterium fusiforme </span></td>
<td align="left" valign="top"><span class="Italics">Mycoplasma pneumoniae </span></td>
</tr>
<tr>
<td align="left" valign="top"><span class="Italics">Propionibacterium <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span></span></td>
<td align="left" valign="top"><span class="Italics">Rickettsiae </span></td>
</tr>
<tr>
<td align="left" valign="top">
<span class="Italics">Treponema pallidum </span>subspecies<span class="Italics"> pallidum </span>
</td>
<td align="left" valign="top">
<span class="Italics">Treponema pallidum </span>subspecies<span class="Italics"> pertenue </span>
</td>
</tr>
<tr class="Last">
<td valign="top">Ureaplasma urealyticum</td>
<td align="left" valign="top"></td>
</tr>
</tbody>
</table>
<p><span class="Bold">Susceptibility Tests </span></p>
<p><span class="Italics">Dilution Techniques </span></p>
<p>Quantitative methods are used to determine antimicrobial <span class="product-label-link" type="condition" conceptid="4190299" conceptname="Broth microdilution susceptibility test">minimum inhibitory concentrations</span> (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized procedure. Standardized procedures are based on a dilution method (broth or agar) or equivalent with standardized inoculum concentrations and standardized concentrations of demeclocycline hydrochloride or tetracycline powder.<span class="Sup">1</span> The MIC values should be interpreted according to the following criteria:</p>
<p>For organisms other than <span class="Italics">Haemophilus </span>species, <span class="Italics">Neisseria gonorrhoeae </span>and <span class="Italics">Streptococcus</span>species:<span class="Sup"> 2</span></p>
<table frame="void" width="336">
<thead><tr class="First Last">
<td align="left" valign="middle"> MIC (mcg/mL)</td>
<td align="left" valign="middle"> Interpretation</td>
</tr></thead>
<tbody>
<tr class="First">
<td align="center" valign="middle">â‰¤ 4</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Susceptible (S)</td>
</tr>
<tr>
<td align="center" valign="middle">8</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Intermediate (I)</td>
</tr>
<tr class="Last">
<td align="center" valign="middle">â‰¥16</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Resistant (R)</td>
</tr>
</tbody>
</table>
<p>For <span class="Italics">Haemophilus </span>and <span class="Italics">Streptococcus </span>species:<span class="Sup"> 2</span></p>
<table frame="void" width="336">
<thead><tr class="First Last">
<td align="left" valign="middle"> MIC (mcg/mL)</td>
<td align="left" valign="middle"> Interpretation</td>
</tr></thead>
<tbody>
<tr class="First">
<td align="center" valign="middle">â‰¤ 2</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Susceptible (S)</td>
</tr>
<tr>
<td align="center" valign="middle">4</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Intermediate (I)</td>
</tr>
<tr class="Last">
<td align="center" valign="middle">â‰¥8</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Resistant (R)</td>
</tr>
</tbody>
</table>
<p>For <span class="Italics">Neisseria gonorrhoeae</span>:<span class="Sup"> 2</span></p>
<table frame="void" width="336">
<thead><tr class="First Last">
<td align="left" valign="middle"> MIC (mcg/mL)</td>
<td align="left" valign="middle"> Interpretation</td>
</tr></thead>
<tbody>
<tr class="First">
<td align="center" valign="middle">â‰¤ 0.25</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Susceptible (S)</td>
</tr>
<tr>
<td align="center" valign="middle">0.5 to 1</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Intermediate (I)</td>
</tr>
<tr class="Last">
<td align="center" valign="middle">â‰¥2</td>
<td align="left" valign="middle">Â Â Â Â Â Â Â  Resistant (R)</td>
</tr>
</tbody>
</table>
<p>A report of â€œSusceptibleâ€? indicates that the pathogen is likely to be inhibited by usually achievable concentrations of the antimicrobial compound in blood. A report of â€œIntermediateâ€? indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone which prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of â€œResistantâ€? indicates that usually achievable concentrations of the antimicrobial compound in the blood are unlikely to be inhibitory and that other therapy should be selected.</p>
<p>Standardized susceptibility test procedures require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures. Standard demeclocycline or tetracycline powder should provide the following MIC values:<span class="Sup"> 2</span></p>
<table frame="void" width="10000%">
<thead><tr class="First Last">
<td align="left" valign="top"><span class="Bold">Microorganism</span></td>
<td align="left" valign="top"><span class="Bold">MIC (mcg/mL)</span></td>
<td align="left" valign="top"><span class="Bold">Microorganism</span></td>
<td align="left" valign="top"><span class="Bold">MIC (mcg/mL)</span></td>
</tr></thead>
<tbody>
<tr class="First">
<td align="left" valign="top">
<span class="Italics">E.coli, </span>ATCC 25922</td>
<td align="center" valign="top">1 to 4</td>
<td align="left" valign="top">
<span class="Italics">N. gonorrhoeae, </span> ATCC 49226</td>
<td align="center" valign="top">0.25 to 1</td>
</tr>
<tr>
<td align="left" valign="top">
<span class="Italics">E. faecalis,</span> ATCC 29212</td>
<td align="center" valign="top">8 to 32</td>
<td align="left" valign="top">
<span class="Italics">S. aureus, </span>ATCC 29213</td>
<td align="center" valign="top">0.25 to 1</td>
</tr>
<tr class="Last">
<td align="left" valign="top">
<span class="Italics">H. influenzae, </span>ATCC 49247</td>
<td align="center" valign="top">4 to 32</td>
<td align="left" valign="top">
<span class="Italics">S. pneumoniae, </span>ATCC 49619</td>
<td align="center" valign="top">0.12 to 0.5</td>
</tr>
</tbody>
</table>
<p><span class="Italics">Diffusion Techniques </span><br>Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure requires the use of standardized inoculum concentrations.<span class="Sup">2</span> This procedure uses paper disks impregnated with 30-mcg tetracycline (as a class disk) or a 30-mcg demeclocycline hydrochloride disk to test the susceptibility of microorganisms to demeclocycline.<br>Reports from the laboratory providing results of the standard single-disk susceptibility test with either a 30-mcg tetracycline-class disk or a 30-mcg demeclocycline disk should be interpreted according to the following criteria:<br>For organisms other than <span class="Italics">Haemophilus </span>species,<span class="Italics"> Neisseria gonorrhoeae </span>and<span class="Italics"> Streptococcus</span> species:<span class="Sup"> 2</span></p>
<table frame="void" width="455">
<thead><tr class="First Last">
<td align="left" valign="top"><span class="Bold">Zone Diameter (mm)</span></td>
<td align="left" valign="top"><span class="Bold">Interpretation</span></td>
</tr></thead>
<tbody>
<tr class="First">
<td align="center" valign="top">â‰¥ 19</td>
<td align="center" valign="top">Susceptible (S)</td>
</tr>
<tr>
<td align="center" valign="top">15 to 18 </td>
<td align="center" valign="top">Intermediate (I)</td>
</tr>
<tr class="Last">
<td align="center" valign="top">â‰¤ 14</td>
<td align="center" valign="top">Resistant (R)</td>
</tr>
</tbody>
</table>
<p>For <span class="Italics">Haemophilus </span>species:<span class="Sup"></span><span class="Sup">2</span></p>
<table frame="void" width="455">
<thead><tr class="First Last">
<td align="center" valign="top"><span class="Bold">Zone Diameter (mm)</span></td>
<td align="left" valign="top"><span class="Bold">Interpretation</span></td>
</tr></thead>
<tbody>
<tr class="First">
<td align="center" valign="top">â‰¥ 29</td>
<td align="center" valign="top">Susceptible (S)</td>
</tr>
<tr>
<td align="center" valign="top">26 to 28 </td>
<td align="center" valign="top">Intermediate (I)</td>
</tr>
<tr class="Last">
<td align="center" valign="top">â‰¤ 25</td>
<td align="center" valign="top">Resistant (R)</td>
</tr>
</tbody>
</table>
<p>For <span class="Italics">N. gonorrhoeae</span>:<span class="Sup"></span><span class="Sup">2</span></p>
<table frame="void" width="455">
<thead><tr class="First Last">
<td align="center" valign="top"><span class="Bold">Zone Diameter (mm)</span></td>
<td align="left" valign="top"><span class="Bold">Interpretation</span></td>
</tr></thead>
<tbody>
<tr class="First">
<td align="center" valign="top">â‰¥ 38</td>
<td align="center" valign="top">Susceptible (S)</td>
</tr>
<tr>
<td align="center" valign="top">31 to 37 </td>
<td align="center" valign="top">Intermediate (I)</td>
</tr>
<tr class="Last">
<td align="center" valign="top">â‰¤ 30</td>
<td align="center" valign="top">Resistant (R)</td>
</tr>
</tbody>
</table>
<p>For <span class="Italics">Streptococcus </span>species:<span class="Sup"></span><span class="Sup">2</span></p>
<table frame="void" width="455">
<thead><tr class="First Last">
<td align="center" valign="top"><span class="Bold">Zone Diameter (mm)</span></td>
<td align="center" valign="top"><span class="Bold">Interpretation</span></td>
</tr></thead>
<tbody>
<tr class="First">
<td align="center" valign="top">â‰¥ 23</td>
<td align="center" valign="top">Susceptible (S)</td>
</tr>
<tr>
<td align="center" valign="top">19 to 22 </td>
<td align="center" valign="top">Intermediate (I)</td>
</tr>
<tr class="Last">
<td align="center" valign="top">â‰¤ 18</td>
<td align="center" valign="top">Resistant (R)</td>
</tr>
</tbody>
</table>
<p>Interpretation should be as stated above for results using dilution techniques. Interpretation involves correlation of the diameter obtained in the disk test with the MIC for demeclocycline hydrochloride or tetracycline.</p>
<p><br>As with standardized dilution techniques, diffusion methods require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures. For the diffusion technique, the 30-mcg demeclocycline hydrochloride disk or the 30-mcg tetracycline-class disk should provide the following zone diameters in these laboratory test quality control <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span>:<span class="Sup"> 2</span></p>
<table frame="void" width="455">
<thead><tr class="First Last">
<td align="left" valign="top"><span class="Bold">Microorganism</span></td>
<td align="center" valign="top"><span class="Bold">Zone Diameter (mm)</span></td>
</tr></thead>
<tbody>
<tr class="First">
<td align="left" valign="top">
<span class="Italics">E. coli</span>, ATCC 25922</td>
<td align="center" valign="top">18 to 25</td>
</tr>
<tr>
<td align="left" valign="top">
<span class="Italics">H. influenzae, </span>ATCC 49247</td>
<td align="center" valign="top">14 to 22</td>
</tr>
<tr>
<td align="left" valign="top">
<span class="Italics">N. gonorrhoeae</span>, ATCC 49226</td>
<td align="center" valign="top">30 to 42</td>
</tr>
<tr>
<td align="left" valign="top">
<span class="Italics">S. aureus</span>, ATCC 25923</td>
<td align="center" valign="top">24 to 30</td>
</tr>
<tr class="Last">
<td align="left" valign="top">
<span class="Italics">S. pneumoniae</span>, ATCC 49619</td>
<td align="center" valign="top">27 to 31</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS &amp; USAGE
</span></h1>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of demeclocycline hydrochloride tablets and other antibacterial drugs, demeclocycline hydrochloride tablets should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by susceptible bacteria.Â  When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.Â  In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.<br>Demeclocycline hydrochloride is indicated in the treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the designated microorganisms in the conditions below:<br></p>
<p>Rocky Mountain spotted <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, typhus <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and the typhus group, Q <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, rickettsialpox, and tick <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fevers</span> caused by rickettsiae;<br><br><span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">Respiratory tract infections</span> caused by <span class="Italics">Mycoplasma pneumoniae</span>;<br><br>Lymphogranuloma venereum due to <span class="Italics">Chlamydia trachomatis</span>;<br><br>Psittacosis (Ornithosis) due to <span class="Italics">Chlamydia psittaci</span>;<br><br>Trachoma due to <span class="Italics">Chlamydia trachomatis</span>, although the infectious agent is not always eliminated, as judged by immunofluorescence;<br><br>Inclusion <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> caused by <span class="Italics">Chlamydia trachomatis</span>;<br><br>Nongonococcal <span class="product-label-link" type="condition" conceptid="195862" conceptname="Urethritis">urethritis</span> in adults caused by <span class="Italics">Ureaplasma urealyticum </span>or <span class="Italics">Chlamydia trachomatis</span>;<br><br><span class="product-label-link" type="condition" conceptid="440637" conceptname="Relapsing fever">Relapsing fever</span> due to <span class="Italics">Borrelia recurrentis</span>;<br><br><span class="product-label-link" type="condition" conceptid="138973" conceptname="Chancroid">Chancroid</span> caused by <span class="Italics">Haemophilus ducreyi</span>;<br><br><span class="product-label-link" type="condition" conceptid="434271" conceptname="Plague">Plague</span> due to <span class="Italics">Yersinia pestis</span>;<br><br>Tularemia due to <span class="Italics">Francisella tularensis</span>;<br><br><span class="product-label-link" type="condition" conceptid="198677" conceptname="Cholera">Cholera</span> caused by <span class="Italics">Vibrio cholerae</span>;<br><br>Campylobacter fetus <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by <span class="Italics">Campylobacter fetus</span>;<br><br><span class="product-label-link" type="condition" conceptid="441497" conceptname="Brucellosis">Brucellosis</span> due to <span class="Italics">Brucella </span>species (in conjunction with streptomycin);<br><br>Bartonellosis due to <span class="Italics">Bartonella bacilliformis</span>;<br><br><span class="product-label-link" type="condition" conceptid="199726" conceptname="Granuloma inguinale">Granuloma inguinale</span> caused by <span class="Italics">Calymmatobacterium granulomatis</span>;<br><br>Demeclocycline hydrochloride is indicated for treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug:<br><br><span class="Italics">Escherichia coli</span>;<br><br><span class="Italics">Enterobacter aerogenes</span>;<br><br><span class="Italics">Shigella </span>species;<br><br><span class="Italics">Acinetobacter </span>species; <span class="Italics"><br></span><span class="Italics"><br></span><span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">Respiratory tract infections</span> caused by <span class="Italics">Haemophilus influenzae</span>; <br><br>Respiratory tract and <span class="product-label-link" type="condition" conceptid="81902" conceptname="Urinary tract infectious disease">urinary tract infections</span> caused by <span class="Italics">Klebsiella </span>species.<br><br>Demeclocycline hydrochloride is indicated for treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by the following gram-positive microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug:<br><br><span class="product-label-link" type="condition" conceptid="4181583" conceptname="Upper respiratory infection">Upper respiratory infections</span> caused by <span class="Italics">Streptococcus </span>pneumoniae;<br>Skin and skin structure <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by <span class="Italics">Staphylococcus aureus</span>. <br>(Note: Tetracyclines, including demeclocycline, are not the drugs of choice in the treatment of any type of <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infection</span>.)<br>When penicillin is contraindicated, tetracyclines, including demeclocycline hydrochloride, are alternative drugs in the treatment of the following <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>:<br><br>Uncomplicated <span class="product-label-link" type="condition" conceptid="195862" conceptname="Urethritis">urethritis</span> in men due to <span class="Italics">Neisseria gonorrhoeae</span>, and for the treatment of other uncomplicated gonococcal <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>;<br><br><span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infections</span> in women caused by <span class="Italics">Neisseria gonorrhoeae</span>;<br><br><span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">Syphilis</span> caused by <span class="Italics">Treponema pallidum </span>subspecies <span class="Italics">pallidum</span>;<br><br>Yaws caused by<span class="Italics"> Treponema pallidum </span>subspecies<span class="Italics"> pertenue</span>;<br><br><span class="product-label-link" type="condition" conceptid="438059" conceptname="Listeriosis">Listeriosis</span> due to <span class="Italics">Listeria monocytogenes</span>;<br><br><span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">Anthrax</span> due to <span class="Italics">Bacillus anthracis</span>;<br><br>Vincentâ€™s <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> caused by <span class="Italics">Fusobacterium fusiforme</span>;<br><br><span class="product-label-link" type="condition" conceptid="436020" conceptname="Actinomycotic infection">Actinomycosis</span> caused by <span class="Italics">Actinomyces israelii</span>;<br><br>Clostridial diseases caused by <span class="Italics">Clostridium </span>species.<br><br>In acute intestinal <span class="product-label-link" type="condition" conceptid="438959" conceptname="Amebic infection">amebiasis</span>, demeclocycline hydrochloride may be a useful adjunct to amebicides.<br><br>In severe <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span>, demeclocycline hydrochloride may be a useful adjunctive therapy.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS
</span></h1>
<p class="First"><br>This drug is contraindicated in persons who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the tetracyclines or any of the components of the product formulation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS
</span></h1>
<p class="First"><span class="Bold"><br></span>DEMECLOCYCLINE HYDROCHLORIDE, LIKE OTHER TETRACYCLINE-CLASS ANTIBIOTICS, CAN CAUSE FETAL HARM WHEN ADMINISTERED TO A PREGNANT WOMAN. IF ANY TETRACYCLINE IS USED DURING PREGNANCY, OR IF THE PATIENT BECOMES PREGNANT WHILE TAKING THESE DRUGS, THE PATIENT SHOULD BE APPRISED OF THE POTENTIAL HAZARD TO THE FETUS.</p>
<p>THE USE OF DRUGS OF THE TETRACYCLINE CLASS DURING TOOTH DEVELOPMENT (LAST HALF OF PREGNANCY, INFANCY AND CHILDHOOD TO THE AGE OF 8 YEARS) MAY CAUSE PERMANENT DISCOLORATION OF THE TEETH (YELLOW-GRAY-BROWN). This adverse reaction is more common during long-term use of the drugs but has been observed following repeated short-term courses. <span class="product-label-link" type="condition" conceptid="4131814" conceptname="Enamel hypoplasia">Enamel hypoplasia</span> has also been reported. TETRACYCLINE DRUGS, THEREFORE, SHOULD NOT BE USED DURING TOOTH DEVELOPMENT UNLESS OTHER DRUGS ARE NOT LIKELY TO BE EFFECTIVE OR ARE CONTRAINDICATED.</p>
<p>All tetracyclines form a stable calcium complex in any bone-forming tissue. A decrease in fibula growth rate has been observed in premature human infants given oral tetracycline in doses of 25 mg/kg every six hours. This reaction was shown to be reversible when the drug was discontinued.</p>
<p>Results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues, and can have toxic effects on the developing fetus (often related to retardation of skeletal development). Evidence of embryotoxicity has also been noted in animals treated early in pregnancy.</p>
<p>The anti-anabolic action of the tetracyclines may cause an increase in BUN. While this is not a problem in those with normal renal function, in patients with significantly impaired function, higher serum levels of tetracycline may lead to <span class="product-label-link" type="condition" conceptid="4261202" conceptname="Uremia">azotemia</span>, <span class="product-label-link" type="condition" conceptid="4065502" conceptname="Hyperphosphatemia">hyperphosphatemia</span>, and <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span>.</p>
<p>If <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> exists, even usual oral or parenteral doses may lead to excessive systemic accumulation of the drug and possible liver toxicity. Under such conditions, lower than usual total doses are indicated and, if therapy is prolonged, serum level determinations of the drug may be advisable.</p>
<p><span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">Photosensitivity</span> manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. Phototoxic reactions can occur in individuals taking demeclocycline, and are characterized by severe <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span> of exposed surfaces resulting from direct exposure of patients to sunlight during therapy with moderate or large doses of demeclocycline. Patients apt to be exposed to direct sunlight or ultraviolet light should be advised that this reaction can occur, and treatment should be discontinued at the first evidence of <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> of the skin.</p>
<p>Administration of demeclocycline hydrochloride has resulted in appearance of the <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">diabetes insipidus</span> syndrome (<span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span>, <span class="product-label-link" type="condition" conceptid="432454" conceptname="Excessive thirst">polydipsia</span> and <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>) in some patients on long-term therapy. The syndrome has been shown to be nephrogenic, dose-dependent and reversible on discontinuance of therapy.</p>
<p>Patients who are experiencing central nervous system symptoms associated with demeclocycline therapy, should be cautioned about driving vehicles or using hazardous machinery while on demeclocycline therapy.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS
</span></h1>
<p class="First"><span class="Bold">General</span><span class="Bold"><br></span>Prescribing demeclocycline hydrochloride tablets in the absence of a proven or strongly suspected <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span> or a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> indication is unlikely to provide benefit to the patient and increase the risk of the development of drug-resistant bacteria.</p>
<p><span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">Pseudotumor cerebri</span> (<span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">benign intracranial hypertension</span>) in adults has been associated with the use of tetracyclines. The usual clinical manifestations are <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> and <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>. Bulging fontanels have been associated with the use of tetracyclines in infants. While both of these conditions and related symptoms usually resolve soon after discontinuation of the tetracycline, the possibility for permanent sequelae exists.</p>
<p>As with other antibiotic preparations, use of this drug may result in overgrowth of nonsusceptible organisms, including fungi. If <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfection</span> occurs, the antibiotic should be discontinued and appropriate therapy should be instituted.</p>
<p>Incision and drainage or other surgical procedures should be performed in conjunction with antibiotic therapy, when indicated.</p>
<p><span class="Bold">Information for Patients </span><span class="Bold"><br></span><span class="Bold"><br></span>Patients should be counseled that antibacterial drugs including demeclocycline hydrochloride tablets should only be used to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>.Â  They do not treat <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> (e.g. the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>).Â  When demeclocycline hydrochloride tablets are prescribed to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span>, patients should be told that although it is common to fell better early in the course of therapy, the medication should be taken exactly as directed.Â  Skipping doses or not completing the full course of therapy (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by demeclocycline hydrochloride tablets or other antibacterial drugs in the future.</p>
<p><span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">Photosensitivity</span> manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. Patients apt to be exposed to direct sunlight or ultraviolet light should be advised that this reaction can occur with tetracycline drugs, and treatment should be discontinued at the first evidence of <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">skin erythema</span>.</p>
<p>Concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective. (See <span class="Bold">Drug Interactions</span>.)</p>
<p>Patients should be informed that demeclocycline hydrochloride tablets should be taken at least 1 hour before meals or 2 hours after meals. (See <span class="Bold">DOSAGE AND ADMINISTRATION</span>.)</p>
<p>Unused supplies of tetracycline antibiotics should be discarded by the expiration date.</p>
<p>Patients who are experiencing <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, light-headedness, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>, or <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span> while on demeclocycline therapy, should be cautioned about driving vehicles or using hazardous machinery while receiving demeclocycline therapy. (See <span class="Bold">WARNINGS</span>.)</p>
<p><span class="Bold">Laboratory Tests </span></p>
<p>In venereal diseases when coexistent <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> is suspected, darkfield examination should be done before treatment is started and the blood serology repeated monthly for at least 4 months.</p>
<p>In long-term therapy, periodic laboratory evaluation of organ systems, including hematopoietic, renal, and hepatic, should be performed.</p>
<p>All patients with <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span> should have a serologic test for <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> at <br>the time of diagnosis. Patients treated with demeclocycline hydrochloride should have a follow-up serologic test for <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> after 3 months.</p>
<p><span class="Bold">Drug Interactions </span></p>
<p>Because tetracyclines have been shown to depress plasma <span class="product-label-link" type="condition" conceptid="4173906" conceptname="Clotting factor II assay">prothrombin</span> activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.</p>
<p>Since bacteriostatic drugs may interfere with the bactericidal action of penicillins, it is advisable to avoid giving tetracycline-class drugs in conjunction with penicillin.</p>
<p>Concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective.</p>
<p>The concurrent use of tetracyclines and methoxyflurane has been reported to result in fatal renal toxicity.</p>
<p>Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and by iron-containing preparations.</p>
<p><span class="Bold">Carcinogenesis, Mutagenesis, Impairment of Fertility </span><span class="Bold"><br></span><br>Long-term studies in animals to evaluate carcinogenic potential of demeclocycline hydrochloride have not been conducted. However, there has been evidence of oncogenic activity in rats in studies with the related antibiotics oxytetracycline (adrenal and pituitary tumors) and minocycline (<span class="product-label-link" type="condition" conceptid="4030041" conceptname="Thyroid nodule">thyroid tumors</span>).</p>
<p>Although mutagenicity studies of demeclocycline hydrochloride have not been conducted, positive results in <span class="Italics">in vitro </span>mammalian cell assays (i.e., mouse <span class="product-label-link" type="condition" conceptid="432571" conceptname="Malignant lymphoma">lymphoma</span> and Chinese hamster lung cells) have been reported for related antibiotics (tetracycline hydrochloride and oxytetracycline). (See <span class="Bold">WARNINGS </span>and <span class="Bold">ANIMAL PHARMACOLOGY AND ANIMAL TOXICOLOGY</span>.)</p>
<p>Demeclocycline hydrochloride had no effect on fertility when administered in the diet to male and female rats at a daily intake of 45 times the human dose.</p>
<p><span class="Bold">Pregnancy </span><span class="Bold"><br></span><span class="Bold"><br></span><span class="Italics">Teratogenic effects. Pregnancy Category D</span>. (See <span class="Bold">WARNINGS</span>.)</p>
<p>Results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues, and can have toxic effects on the developing fetus (often related to retardation of skeletal development). Evidence of embryotoxicity has been noted in animals treated early in pregnancy.</p>
<p><span class="Italics">Nonteratogenic effects. </span>(See <span class="Bold">WARNINGS</span>.)</p>
<p><span class="Bold">Labor and Delivery </span><span class="Bold"><br></span><span class="Bold"><br></span>The effect of tetracyclines on labor and delivery is unknown.</p>
<p><span class="Bold">Nursing Mothers</span><span class="Bold"><br></span><span class="Bold"><br></span>Tetracyclines are excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from the tetracyclines, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.</p>
<p>(See <span class="Bold">WARNINGS</span>.)</p>
<p><span class="Bold">Pediatric Use</span><span class="Bold"><br></span><span class="Bold"><br></span>Not for use in patients younger than eight years of age. See <span class="Bold">WARNINGS</span>, <span class="Bold">PRECAUTIONS </span>(<span class="Bold">General </span>subsection) and <span class="Bold">DOSAGE AND ADMINISTRATION</span>.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS
</span></h1>
<p class="First"><br>The following reactions have been reported in patients receiving tetracyclines:</p>
<p>Gastrointestinal: <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">Anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="436147" conceptname="Glossitis">glossitis</span>, <span class="product-label-link" type="condition" conceptid="31317" conceptname="Dysphagia">dysphagia</span>, <span class="product-label-link" type="condition" conceptid="4184503" conceptname="Enterocolitis">enterocolitis</span>, <span class="product-label-link" type="condition" conceptid="4192640" conceptname="Pancreatitis">pancreatitis</span>, and inflammatory lesions (with monilial overgrowth) in the anogenital region, increases in liver enzymes, and hepatic toxicity has been reported rarely.</p>
<p>Rarely, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span> and <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span> have been reported. These reactions have been caused by both the oral and parenteral administration of tetracyclines.</p>
<p>Instances of <span class="product-label-link" type="condition" conceptid="25844" conceptname="Ulcer of esophagus">esophageal ulcerations</span> have been reported in patients receiving oral tetracyclines. Most of the patients were reported to have taken the medication immediately before lying down. (See <span class="Bold">DOSAGE AND ADMINISTRATION</span>.)</p>
<p>Skin: Maculopapular and erythematous <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rashes</span>, <span class="product-label-link" type="condition" conceptid="132702" conceptname="Erythema multiforme">erythema multiforme</span>. <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">Exfoliative dermatitis</span> has been reported but is uncommon. <span class="product-label-link" type="condition" conceptid="4080559" conceptname="Baboon syndrome">Fixed drug eruptions</span> and <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span> have been reported rarely. Lesions occurring on the glans penis have caused <span class="product-label-link" type="condition" conceptid="436466" conceptname="Balanoposthitis">balanitis</span>. <span class="product-label-link" type="condition" conceptid="4083855" conceptname="Abnormal pigment">Pigmentation</span> of the skin and mucous membranes has also been reported. <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">Photosensitivity</span> is discussed above. (See <span class="Bold">WARNINGS</span>.)</p>
<p>Renal toxicity: <span class="product-label-link" type="condition" conceptid="197320" conceptname="Acute renal failure syndrome">Acute renal failure</span>. Rise in BUN has been reported and is apparently dose related. <span class="product-label-link" type="condition" conceptid="438476" conceptname="Nephrogenic diabetes insipidus">Nephrogenic diabetes insipidus</span>. (See <span class="Bold">WARNINGS</span>.)</p>
<p><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span>: <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioneurotic edema</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">polyarthralgia</span>, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, <span class="product-label-link" type="condition" conceptid="4101602" conceptname="Henoch-Schonlein purpura">anaphylactoid purpura</span>, <span class="product-label-link" type="condition" conceptid="4138837" conceptname="Pericarditis">pericarditis</span>, exacerbation of <span class="product-label-link" type="condition" conceptid="257628" conceptname="Systemic lupus erythematosus">systemic lupus erythematosus</span>, lupus-like syndrome, pulmonary infiltrates with <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span>.</p>
<p>Hematologic: <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">Hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="320073" conceptname="Neutropenia">neutropenia</span> and <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span> have been reported.</p>
<p>CNS: <span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">Pseudotumor cerebri</span> (<span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">benign intracranial hypertension</span>) in adults and bulging fontanels in infants (see <span class="Bold">PRECAUTIONS-General</span>). <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, and <span class="product-label-link" type="condition" conceptid="374034" conceptname="Visual disturbance">visual disturbances</span> have been reported. <span class="product-label-link" type="condition" conceptid="4237155" conceptname="Eaton-Lambert syndrome">Myasthenic syndrome</span> has been reported rarely.</p>
<p>Other: When given over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>, tetracyclines have been reported to produce brown-black microscopic discoloration of thyroid glands. No abnormalities of thyroid function studies are known to occur. Very rare cases of abnormal thyroid function have been reported.</p>
<p><span class="product-label-link" type="condition" conceptid="45757361" conceptname="Mottled teeth">Tooth discoloration</span> has occurred in pediatric patients less than 8 years of age (see <span class="Bold">WARNINGS</span>), and also has been reported rarely in adults.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1><span class="Bold">OVERDOSAGE
</span></h1>
<p class="First">In case of overdosage, discontinue medication, treat symptomatically and institute supportive measures. Tetracyclines are not removed in significant quantities by hemodialysis or peritoneal dialysis.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1><span class="Bold">DOSAGE &amp; ADMINISTRATION
</span></h1>
<p class="First">Therapy should be continued for at least 24 to 48 hours after symptoms and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> have subsided.</p>
<p>Concomitant therapy: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and by iron-containing preparations. Foods and some dairy products also interfere with absorption. Oral forms of tetracycline should be given at least 1 hour before or 2 hours after meals.</p>
<p>In patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>: (See <span class="Bold">WARNINGS</span>.) Tetracyclines should be used cautiously in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Total dosage should be decreased by reduction of recommended individual doses and/or by extending time intervals between doses.</p>
<p>In patients with liver impairment: Tetracyclines should be used cautiously in patients with <span class="product-label-link" type="condition" conceptid="4326594" conceptname="Abnormal liver function">impaired liver function</span>. Total dosage should be decreased by reduction of recommended individual doses and/or by extending time intervals between doses.</p>
<p>Administration of adequate amounts of fluid with the oral formulations of tetracyclines is recommended to wash down the drugs and reduce the risk of esophageal irritation and ulceration. (See <span class="Bold">ADVERSE REACTIONS</span>.)</p>
<p>Adults: Usual daily dose - Four divided doses of 150 mg each or two divided doses of 300 mg each.</p>
<p>For pediatric patients above eight years of age: Usual daily dose, 7 to 13 mg per kg body weight per day, depending upon the severity of the disease, divided into two to four doses not to exceed adult dosage of 600 mg per day.</p>
<p><span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">Gonorrhea</span> patients sensitive to penicillin may be treated with demeclocycline administered as an initial oral dose of 600 mg followed by 300 mg every 12 hours for four days to a total of 3 grams.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED
</span></h1>
<p class="First">Demeclocycline hydrochloride tablets, 150 mg, are round, convex, red, film coated tablets, debossed â€˜ANâ€™ above â€˜54â€™ on one side and plain on the other, and are supplied as follows:</p>
<p>NDC 65162-554-10 â€” Bottle of 100</p>
<p>Demeclocycline hydrochloride tablets, 300 mg, are round, convex, pink, film coated tablets, debossed â€˜AN 55â€™ on one side and plain on the other, and are supplied as follows:</p>
<p>NDC 65162-555-48 â€” Bottle of 48</p>
<p><span class="Bold">Store at 20Â°-25Â°C (68Â°-77Â°F) [See USP Controlled Room Temperature].Â  Dispense contents with a child-resistant closure (as required) and in a tight, light-resistant container as defined in the USP.</span></p>
<p><span class="Bold">ANIMAL PHARMACOLOGY AND ANIMAL TOXICOLOGY </span><span class="Bold"><br></span><span class="Bold"><br></span>Hyperpigmentation of the thyroid has been produced by members of the tetracycline class in the following species: in rats by oxytetracycline, doxycycline, tetracycline PO<span class="Sub">4</span> and methacycline; in minipigs by doxycycline, minocycline, tetracycline PO<span class="Sub">4</span>, and methacycline; in dogs by</p>
<p>doxycycline and minocycline; in monkeys by minocycline.</p>
<p>Minocycline, tetracycline PO<span class="Sub">4</span>, methacycline, doxycycline, tetracycline base, oxytetracycline HCl, and tetracycline HCl were goitrogenic in rats fed a low iodine diet. This goitrogenic effect was accompanied by high radioactive iodine uptake. Administration of minocycline also produced a large <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiter</span> with high radioiodine uptake in rats fed a relatively high iodine diet.</p>
<p>Treatment of various animal species with this class of drugs has also resulted in the induction of <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">thyroid hyperplasia</span> in the following: in rats and dogs (minocycline), in chickens (chlortetracycline), and in rats and mice (oxytetracycline). Adrenal gland <span class="product-label-link" type="condition" conceptid="4296894" conceptname="Hyperplasia">hyperplasia</span> has been observed in goats and rats treated with oxytetracycline.</p>
<p><span class="Bold">REFERENCES</span><span class="Bold"><br></span><span class="Bold"><br></span>1.Â Â  National Committee for Clinical Laboratory Standards. (2000).â€œMethods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically.Approved standard M7-A5 and informational supplement M100-S10.â€? National Committee for Clinical Laboratory Standards, Wayne, PA.<br>2. National Committee for Clinical Laboratory Standards. (2000). â€œPerformance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A7.â€?National Committee for Clinical Laboratory Standards, Wayne, PA.<br>3. National Committee for Clinical Laboratory Standards. (2002).â€œPerformance standards for antimicrobial susceptibility testing. Twelfth informational supplement. M100-S12.â€? National Committee for Clinical Laboratory Standards, Wayne, PA.</p>
<p>Manufactured by:</p>
<p><span class="Bold">Amneal Pharmaceuticals</span><span class="Bold"><br></span>Paterson, New Jersey 07504<br></p>
<p>MF # 639									Rev: 10/07</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-12"></a><p></p>
<h1><span class="Bold">PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
</span></h1>
<div class="Figure"><img alt="8849f977-figure-02" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4ff23e3b-e111-47fd-9776-1d89d6da049b&amp;name=8849f977-figure-02.jpg"></div>
<div class="Figure"><img alt="8849f977-figure-03" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4ff23e3b-e111-47fd-9776-1d89d6da049b&amp;name=8849f977-figure-03.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DEMECLOCYCLINE HYDROCHLORIDEÂ 		
					</strong><br><span class="contentTableReg">demeclocycline hydrochloride tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:65162-554</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DEMECLOCYCLINE HYDROCHLORIDE</strong> (DEMECLOCYCLINE) </td>
<td class="formItem">DEMECLOCYCLINE HYDROCHLORIDE</td>
<td class="formItem">150Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALGINIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ETHYLCELLULOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C RED NO. 40</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HYPROMELLOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYVINYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TALC</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C RED NO. 27</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">RED</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">9mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">AN;54</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Demeclocycline Hydrochloride</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:65162-554-10</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA065425</td>
<td class="formItem">04/01/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DEMECLOCYCLINE HYDROCHLORIDEÂ 		
					</strong><br><span class="contentTableReg">demeclocycline hydrochloride tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:65162-555</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DEMECLOCYCLINE HYDROCHLORIDE</strong> (DEMECLOCYCLINE) </td>
<td class="formItem">DEMECLOCYCLINE HYDROCHLORIDE</td>
<td class="formItem">300Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALGINIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ETHYLCELLULOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C RED NO. 40</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HYPROMELLOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYVINYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TALC</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">PINK</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">20mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">AN;54</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Demeclocycline Hydrochloride</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:65162-555-48</td>
<td class="formItem">48  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA065425</td>
<td class="formItem">04/01/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Amneal Pharmaceuticals
							(804220023)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Amneal Pharmaceuticals (831227801)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Amneal Pharmaceuticals</td>
<td class="formItem"></td>
<td class="formItem">123797875</td>
<td class="formItem">ANALYSIS, LABEL, MANUFACTURE, PACK</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>8849f977-0448-4a3e-bd96-ee1b8791fefa</div>
<div>Set id: 4ff23e3b-e111-47fd-9776-1d89d6da049b</div>
<div>Version: 1</div>
<div>Effective Time: 20100401</div>
</div>
</div>Â <div class="DistributorName">Amneal Pharmaceuticals</div></p>
</body></html>
